Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line.

Carla Luis, Yuselis Castaño-Guerrero, Raquel Soares, Goreti Sales, Rúben Fernandes
Author Information
  1. Carla Luis: School of Health, Polytechnic Institute of Porto, 4200 Porto, Portugal. karlaluiz@hotmail.com. ORCID
  2. Yuselis Castaño-Guerrero: BioMark-CEB/ISEP, School of Engineering, Polytechnic Institute of Porto, 4200 Porto, Portugal. ycastano87@gmail.com. ORCID
  3. Raquel Soares: Institute of Research and Innovation in Health (i3S), Porto University, 4200 Porto, Portugal. raqsoa@med.up.pt.
  4. Goreti Sales: BioMark-CEB/ISEP, School of Engineering, Polytechnic Institute of Porto, 4200 Porto, Portugal. goreti.sales@gmail.com. ORCID
  5. Rúben Fernandes: School of Health, Polytechnic Institute of Porto, 4200 Porto, Portugal. rfernandes@ess.ipp.pt. ORCID

Abstract

Doxorubicin (DOXO) is an adjuvant chemotherapy agent and is also commonly used in cell biology research. Cytotoxic assays in cell culture are frequently used in order to stablish drug concentrations that are useful for controlling cell proliferation. One common cytotoxic method used is 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT). Our present research aims to support future studies in engaging MTT assay using DOXO that exhibits a strong red coloration and fluorescence, and so it is assumed that DOXO may interfere with commonly used colorimetric assays such as MTT. The interference of DOXO in the MTT determination was evaluated in a Breast Cancer cell line Michigan Cancer Foundation-7 (MCF-7). The interference was evaluated by means of spectroscopic methods in particular spectrophometry and fluorescence spectroscopy of MTT and DOXO. We postulate that the medium and the MTT reagent itself can interfere on the metabolic activity method, so in order to achieve better results, DMEM was replaced by a neutral buffer like Phosphate-buffered saline (PBS). This protocol may be extremely useful in future studies involving DOXO.

Keywords

References

  1. Biotechnol Annu Rev. 2005;11:127-52 [PMID: 16216776]
  2. Br J Cancer. 1987 Sep;56(3):279-85 [PMID: 3663476]
  3. J Immunol Methods. 1983 Dec 16;65(1-2):55-63 [PMID: 6606682]
  4. J Clin Oncol. 1993 Jun;11(6):1132-43 [PMID: 8501500]

Word Cloud

Created with Highcharts 10.0.0MTTDOXOusedcellCancerMCF-7DoxorubicinchemotherapycommonlyresearchassaysorderusefulmethodfuturestudiesfluorescencemayinterfereinterferenceevaluatedBreastadjuvantagentalsobiologyCytotoxicculturefrequentlystablishdrugconcentrationscontrollingproliferationOnecommoncytotoxic3-45-Dimethylthiazol-2-yl-25-DiphenyltetrazoliumBromidepresentaimssupportengagingassayusingexhibitsstrongredcolorationassumedcolorimetricdeterminationlineMichiganFoundation-7meansspectroscopicmethodsparticularspectrophometryspectroscopypostulatemediumreagentcanmetabolicactivityachievebetterresultsDMEMreplacedneutralbufferlikePhosphate-bufferedsalinePBSprotocolextremelyinvolvingAvoidingInterferenceMeasurementsCellLinebreastcancerdoxorubicin

Similar Articles

Cited By